Zantac Maker Recalls The Heartburn Drug After FDA Warning That It May Be Linked To Cancer

Published Oct 18, 2019

Zantac Maker Recalls The Heartburn Drug After FDA Warning That It May Be Linked To Cancer

NOW
PLAYING
PARP Inhibitors Offer Promise, But 'Pills Have Side Effects Too'
NOW
PLAYING
FDA Urges Recall of Diabetes Drug Metformin Due to Cancer Link - How Dangerous is the Medication?
NOW
PLAYING
Ovarian Cancer - New PARP Inhibitor Combination Drug Approval
NOW
PLAYING
The IV Chemotherapy Experience for Ovarian Cancer Patients
NOW
PLAYING
When to Add PARP Inhibitors to Your Ovarian Cancer Treatment
NOW
PLAYING
PARP Inhibitor Side Effects
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.